These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 23253701

  • 1. Anticoagulation therapy in Chinese patients with non-valvular atrial fibrillation: a prospective, multi-center, randomized, controlled study.
    Chen KP, Huang CX, Huang DJ, Cao KJ, Ma CS, Wang FZ, Zhang S.
    Chin Med J (Engl); 2012 Dec; 125(24):4355-60. PubMed ID: 23253701
    [Abstract] [Full Text] [Related]

  • 2. [The randomized study of efficiency and safety of antithrombotic therapy in nonvalvular atrial fibrillation: warfarin compared with aspirin].
    Hu DY, Zhang HP, Sun YH, Jiang LQ, Antithrombotic Therapy in Atrial Fibrillation Study Group.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):295-8. PubMed ID: 16776915
    [Abstract] [Full Text] [Related]

  • 3. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE.
    N Engl J Med; 2003 Sep 11; 349(11):1019-26. PubMed ID: 12968085
    [Abstract] [Full Text] [Related]

  • 4. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
    Takarada K, Sato M, Goto M, Saito A, Ikeda Y, Fujita S, Fuse K, Takahashi M, Oguro T, Matsushita H, Kitazawa H, Okabe M, Abe H, Toba K, Yamashina A, Aizawa Y.
    J Cardiol; 2014 Aug 11; 64(2):127-32. PubMed ID: 24440439
    [Abstract] [Full Text] [Related]

  • 5. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial.
    Lancet; 1996 Sep 07; 348(9028):633-8. PubMed ID: 8782752
    [Abstract] [Full Text] [Related]

  • 6. Warfarin compared with aspirin for older Chinese patients with stable coronary heart diseases and atrial fibrillation complications.
    Liu X, Huang H, Yu J, Cao G, Feng L, Xu Q, Zhang S, Zhou M, Li Y.
    Int J Clin Pharmacol Ther; 2014 Jun 07; 52(6):454-9. PubMed ID: 24755126
    [Abstract] [Full Text] [Related]

  • 7. Lower versus standard intensity oral anticoagulant therapy (OAT) in elderly warfarin-experienced patients with non-valvular atrial fibrillation.
    Pengo V, Cucchini U, Denas G, Davidson BL, Marzot F, Jose SP, Iliceto S.
    Thromb Haemost; 2010 Feb 07; 103(2):442-9. PubMed ID: 20076843
    [Abstract] [Full Text] [Related]

  • 8. Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation.
    Koefoed BG, Feddersen C, Gulløv AL, Petersen P.
    Thromb Haemost; 1997 May 07; 77(5):845-8. PubMed ID: 9184390
    [Abstract] [Full Text] [Related]

  • 9. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL, SPORTIF Investigators.
    Am Heart J; 2006 Nov 07; 152(5):967-73. PubMed ID: 17070169
    [Abstract] [Full Text] [Related]

  • 10. Frequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillation.
    Indredavik B, Rohweder G, Lydersen S.
    J Intern Med; 2005 Aug 07; 258(2):133-44. PubMed ID: 16018790
    [Abstract] [Full Text] [Related]

  • 11. [Atrial fibrillation and apoplexy--risks and prevention].
    Koefoed BG, Gulløv AL, Petersen P.
    Nord Med; 1996 Jun 07; 111(6):171-5. PubMed ID: 8700641
    [Abstract] [Full Text] [Related]

  • 12. Anticoagulation and atrial fibrillation.
    Atwood JE, Albers GW.
    Herz; 1993 Feb 07; 18(1):27-38. PubMed ID: 8454250
    [Abstract] [Full Text] [Related]

  • 13. Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic.
    Abdelhafiz AH, Wheeldon NM.
    Clin Ther; 2004 Sep 07; 26(9):1470-8. PubMed ID: 15531009
    [Abstract] [Full Text] [Related]

  • 14. Clinical outcome in Japanese elderly patients with non-valvular atrial fibrillation taking warfarin: a single-center observational study.
    Naganuma M, Shiga T, Sato K, Murasaki K, Hashiguchi M, Mochizuki M, Hagiwara N.
    Thromb Res; 2012 Jul 07; 130(1):21-6. PubMed ID: 22137743
    [Abstract] [Full Text] [Related]

  • 15. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S, Trappolini M, Chillotti FM.
    Minerva Cardioangiol; 2001 Feb 07; 49(1):1-13. PubMed ID: 11279381
    [Abstract] [Full Text] [Related]

  • 16. Secondary Prevention of Stroke with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Subanalysis of the J-RHYTHM Registry.
    Kodani E, Atarashi H, Inoue H, Okumura K, Yamashita T, Origasa H, J-RHYTHM Registry Investigators.
    J Stroke Cerebrovasc Dis; 2016 Mar 07; 25(3):585-99. PubMed ID: 26725259
    [Abstract] [Full Text] [Related]

  • 17. Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials.
    Akins PT, Feldman HA, Zoble RG, Newman D, Spitzer SG, Diener HC, Albers GW.
    Stroke; 2007 Mar 07; 38(3):874-80. PubMed ID: 17255547
    [Abstract] [Full Text] [Related]

  • 18. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.
    Am J Geriatr Pharmacother; 2009 Jun 07; 7(3):159-66. PubMed ID: 19616184
    [Abstract] [Full Text] [Related]

  • 19. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
    Arch Intern Med; 1996 Feb 26; 156(4):409-16. PubMed ID: 8607726
    [Abstract] [Full Text] [Related]

  • 20. Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation.
    Yasaka M, Minematsu K, Yamaguchi T.
    Intern Med; 2001 Dec 26; 40(12):1183-8. PubMed ID: 11813841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.